Repligen
RGEN
#2595
Rank
A$9.52 B
Marketcap
A$169.08
Share price
-0.70%
Change (1 day)
-12.66%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): A$0.12 Billion

According to Repligen 's latest financial reports the company's current earnings are A$0.73 Billion. , an increase over its 2024 earnings that were of -A$9.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 A$0.12 B-1430.84%
2024 -A$9.12 Million-113.01%
2023 A$70.04 M-78.01%
2022 A$0.31 B33.37%
2021 A$0.23 B131.52%
2020 A$0.10 B101.31%
2019 A$51.24 M25.93%
2018 A$40.69 M105.61%
2017 A$19.79 M-11.46%
2016 A$22.35 M14.91%
2015 A$19.45 M20.26%
2014 A$16.17 M-51.49%
2013 A$33.34 M90.98%
2012 A$17.46 M
2010 A$0.25 M-103.81%
2009 -A$6.64 Million-223.84%
2008 A$5.35 M
2006 -A$3.6 Million229.64%
2005 -A$1.1 Million-89.16%
2004 -A$10.08 Million-16.86%
2003 -A$12.12 Million88.72%
2002 -A$6.42 Million-27.88%
2001 -A$8.9 Million-1.74%
2000 -A$9.06 Million85.93%
1999 -A$4.88 Million159.16%
1998 -A$1.88 Million85.71%
1997 -A$1.02 Million-70.83%
1996 -A$3.47 Million-72.41%
1995 -A$12.58 Million-60.63%
1994 -A$31.96 Million45.39%
1993 -A$21.98 Million39.45%
1992 -A$15.76 Million-32.3%
1991 -A$23.28 Million6.62%
1990 -A$21.84 Million1577.78%
1989 -A$1.31 Million-57.14%
1988 -A$3.04 Million-362.5%
1987 A$1.15 M-130.77%
1986 -A$3.76 Million136.36%
1985 -A$1.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.73 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$10.56 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$15.67 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.48 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$0.54 B 346.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.92 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.69 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-A$0.15 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA